An Engineered Arginase FC Protein Inhibits Tumor Growth In Vitro and In Vivo
Arginine is a semiessential amino acid required for the growth of melanoma and hepatocellular carcinoma, and the enzymatic removal of arginine by pegylated arginine deiminase (ADI) or arginase is being tested clinically. Here, we report a genetically engineered arginase FC fusion protein exhibiting...
Main Authors: | Lihua Li, Yan Wang, Jun Chen, Bi Cheng, Jiehua Hu, Yuehua Zhou, Xin Gao, Liucun Gao, Xifan Mei, Meiyan Sun, Zhuomei Zhang, Haifeng Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/423129 |
Similar Items
-
The in vivo & in ritro effects of arginase on murine immunity & on tumor growth
by: Hou, Fang-Yue, et al. -
The in vivo & in ritro effects of arginase on murine immunity & on tumor growth
by: HOU, FANG-YAO, et al.
Published: (1987) -
Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma
by: Anna Sosnowska, et al.
Published: (2021-01-01) -
Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo
by: Makan Khoshnejad, et al.
Published: (2020-09-01) -
Effects of the combined arginase and canavanine treatment on leukemic cells in vitro and in vivo
by: O. I. Vovk, et al.
Published: (2016-04-01)